GLP1Coach

Competitive Intelligence Report | GLP-1 Nutrition Coaching Market

Market Verdict: GO with caution — Significant opportunity in niche, but requires differentiation

Market Opportunity Score: 7.8/10

Executive Summary

GLP1Coach targets a rapidly expanding GLP-1 user base (8-12M in North America) with a specialized nutrition coaching app addressing specific pain points competitors ignore: nausea-triggered meal recommendations, high-protein meal design for muscle preservation, and fridge-to-meal workflows. The market is fragmented with no dominant player offering nausea-specific guidance, creating a defensible positioning opportunity.

Target Pricing: $12.99/month or $99/year

TAM/SAM/SOM: TAM: $1.4-3.6B | SAM: $360M-900M | SOM Y1: $9-30M

Market Context & Opportunity

GLP-1 Market Growth

Global Medication Market

$80-130B (2026)

$255B+ (by 2034)

Health/Nutrition Apps

$6.9-7.5B (2026)

16.6% CAGR growth rate

Active GLP-1 Users

8-12M North America

Rapidly expanding globally

Key Market Insight: The Nausea Gap

Critical Unmet Need: Nausea Management

1 in 5 GLP-1 users experience moderate-to-severe nausea. Zero competitors provide nausea-triggered meal recommendations. This is a massive white space.

Muscle Preservation Protein Gap

Users must consume 80-120g protein daily but face appetite suppression. Most apps offer generic nutrition tracking—none provide specialized high-protein meal design for GLP-1 physiology.

App Fragmentation Pain

Users juggle Shotsy + MyFitnessPal + nutritionist. Opportunity for unified GLP-1-specific nutrition coach that eliminates fragmentation.

Competitive Landscape Overview

Competitor Tier Rating User Base Pricing Model Nausea-Specific? High-Protein Focus?
MeAgain Tier 1 4.8★ 286K+ $9.99/mo app + meds
Shotsy Freemium 4.56★ 2800+ reviews Free + $49.99/yr
Glapp Freemium 5.0★ Growing Free model
Pep Freemium 4.0+★ Moderate Free + Premium
GLP Together New N/A Emerging Free
GLP1Coach Focused Target Launching $12.99/mo or $99/yr

Deep Dive: Top 5 Competitors

1. MeAgain
4.8★ · 286K+ users TIER 1 LEADER

Overview

MeAgain is the market leader, combining medication sourcing ($199/mo tirzepatide, $122/mo semaglutide) with nutrition tracking ($9.99/month app). Targets lifestyle-focused users who want integrated GLP-1 + med management.

Core Features

  • AI photo meal logging with auto-protein/fiber detection
  • Injection day tracking with dose reminders
  • Integrated medication sourcing (direct pharma partnerships)
  • Side effects logging (basic)
  • AI "GLP-1 Coach" companion
  • Shot day prep lists
  • Apple Health integration

Pricing & Monetization

App Subscription
$9.99/mo
Medications
$122-199/mo

Direct sourcing (premium vs. pharma)

Strengths

✓ Market leader with strong user retention (286K+ active)

✓ Vertical integration: app + meds creates switching costs

✓ Medication sourcing differentiator (appeals to uninsured/underinsured)

✓ Strong brand recognition & word-of-mouth

✓ AI companion adds stickiness

Weaknesses

Cannot edit portion sizes in AI meal logging—major UX pain point

✗ Zero nausea-specific meal guidance or side effect personalization

✗ Premium meds pricing ($199/mo) limits TAM to affluent segment

✗ No protein-optimized meal design for muscle preservation

✗ Generic side effect tracking (doesn't anticipate nausea triggers)

✗ High switching costs mean churn is low, but so is growth from alternatives

GLP1Coach Opportunity

→ Position as "the nausea-friendly nutrition coach" vs. MeAgain's "lifestyle tracker"

→ Target users frustrated by MeAgain's portion-size limitation with flexible, intuitive meal logging

→ Offer dedicated high-protein meal design they lack

→ Lower price point ($12.99 vs. $9.99 + meds) for nutrition-only focus

2. Shotsy
4.56★ · 2800+ reviews FREEMIUM LEADER

Overview

Shotsy dominates the freemium tracking space. Free injection/weight/calorie tracking; premium tier ($49.99/yr) unlocks dose estimator and advanced features. Recently raised $2.25M Series A (Feb 2025).

Core Features

  • Injection site rotation tracking
  • Dose reminders & side effect logging
  • Weight charts & estimated medication level graphs
  • Apple Health integration (weight, calories, protein, water)
  • Customizable side effect logs (nausea, headaches, fatigue)
  • Free base app; premium for dose estimation

Pricing & Monetization

Base App
Free
Premium
$49.99/year

Up from $29.99 (Feb 2025)

Strengths

✓ Freemium model drives massive user acquisition (2800+ reviews)

✓ Low friction entry point ($0) = viral growth potential

✓ VC-backed ($2.25M Series A) signals market validation

✓ Strong side effect tracking UI

✓ Peer-reviewed dose estimation (credibility)

Weaknesses

No monetization clarity—free tier too feature-rich; premium tier weak value prop

✗ No nutrition integration—users must toggle to MyFitnessPal (app fragmentation)

✗ Generic nutrition tracking (copied from Apple Health feeds); not specialized

✗ Zero nausea-specific meal guidance

✗ Users duplicate tracking across apps (UX friction)

✗ Recent price hike ($29.99 → $49.99) signals revenue pressure

GLP1Coach Opportunity

→ Target Shotsy users frustrated by app fragmentation with unified nutrition + tracking

→ Offer nausea-triggered meal planning they completely lack

→ Provide high-protein meal design (their strength is only tracking, not coaching)

→ Position as "nutrition-first" vs. Shotsy's "tracking-first"

3. Glapp
5.0★ Trustpilot PRIVACY-FIRST

Overview

Glapp emphasizes privacy and community. Free model with strong Trustpilot reviews (5.0★, 85 reviews). Offers drug concentration estimation and side effect pattern recognition—unique positioning.

Core Features

  • Drug concentration estimation (AI-powered)
  • Side effect pattern recognition & logging
  • Community features (peer support)
  • Weekly reports
  • Multi-language support (English, Turkish, Spanish, Portuguese)
  • Privacy-first: data stays local

Pricing & Monetization

Model
Free

Monetization unclear

Strengths

✓ Privacy-first positioning resonates with health-conscious users

✓ Excellent Trustpilot reviews (5.0★, 95% report faster/clearer results)

✓ Side effect pattern recognition is unique & valuable

✓ Community features reduce user isolation

✓ Multi-language support (global appeal)

Weaknesses

No monetization clarity—free model unsustainable long-term

✗ Weak nutrition tracking (basic, generic)

No meal planning or AI meal logging

✗ No nausea-specific guidance

✗ Community features risk misinformation (medical accuracy concerns)

✗ No site rotation tracking, no multi-med support

GLP1Coach Opportunity

→ Build on Glapp's side effect strengths with nausea-triggered meal recommendations

→ Position as "nutrition coach" where Glapp is "tracker + community"

→ Preserve privacy value prop while adding premium nutrition features

4. Pep
4.0+★ FEATURE-RICH

Overview

Pep is a comprehensive tracker supporting both GLP-1 injections and pills. Offers AI food scanner (photo + barcode), progress photos, habit tracking, and injection site rotation. Freemium model with subscription premium tier.

Core Features

  • Shot + pill tracking (all GLP-1 medications)
  • Estimated medication levels over time
  • AI Food & Barcode Scanner (calorie, protein, fiber estimates)
  • Progress photo tracking (transformation)
  • Habit tracking (weight, measurements, water, macros)
  • Injection site rotation logging
  • Customizable reminders & notifications

Pricing & Monetization

Model
Freemium

Premium pricing TBD

Strengths

✓ Comprehensive feature set (injections, pills, nutrition, habits)

✓ AI food scanner is strong UX feature

✓ Progress photo tracking (psychological motivation)

✓ Multi-medication support (tirzepatide, semaglutide, dulaglutide)

Weaknesses

✗ Requires subscription—moderate adoption friction

✗ Zero nausea-specific guidance or meal personalization

✗ Generic nutrition tracking (no high-protein meal design)

✗ Weak AI meal coaching compared to MeAgain

✗ Moderate user base (less network effect than leaders)

GLP1Coach Opportunity

→ Target Pep users with nausea side effects via specialized meal coaching

→ Position as "nutrition specialist" vs. Pep's "jack-of-all-trades"

→ Offer higher-value nutrition content at comparable price

5. GLP Together
Emerging NEW ENTRANT

Overview

Very new app (launched within 2 weeks of search date). Focuses on free AI meal tracking with community features. Positions against premium-priced competitors with "free alternative" positioning.

Core Features

  • Free AI meal tracking
  • Community features
  • Multi-language support (English, Turkish, Spanish, Portuguese)
  • Privacy-focused approach

Pricing & Monetization

Model
Free

Monetization TBD

Strengths

✓ Free positioning is barrier to entry for premium competitors

✓ Community features provide stickiness

✓ AI meal tracking addresses core pain point

Weaknesses

✗ No monetization model = unsustainable

✗ Basic features (no nausea guidance, no protein optimization)

✗ Too new to assess (no reviews/ratings yet)

✗ No clear differentiation vs. existing competitors

✗ Likely to pivot or shut down if revenue model fails

GLP1Coach Opportunity

→ Offer premium features (nausea coaching, high-protein design) at modest price ($12.99)

→ Position as "specialized coach" vs. GLP Together's "generic tracker"

Feature Comparison Matrix

Feature Category MeAgain Shotsy Glapp Pep GLP Together GLP1Coach
Tracking Features
Injection/Dose Tracking
Side Effect Logging ✓ (nausea-focused)
Weight Tracking
Nutrition Features
AI Meal Logging (Photo/Barcode)
Macro Tracking (Protein/Fiber) △ (Apple Health) ✓ (protein-optimized)
Editable Portion Sizes ✗ (Known Issue)
Nausea-Triggered Meal Recs ✓ (Core Feature)
High-Protein Meal Design ✓ (Core Feature)
Fridge-to-Meal Workflow ✓ (Core Feature)
Community & AI Features
AI Coach/Companion ✓ (Nutrition-focused)
Community Features △ (Optional)
Monetization
Pricing Model $9.99/mo (+ meds) Free + $49.99/yr Free Freemium Free $12.99/mo or $99/yr

Pricing & Monetization Analysis

Competitive Pricing Landscape

MeAgain
$9.99/mo

+ $122-199/mo for meds

Shotsy
$49.99/yr

Free base tier

Pep
Freemium

Premium TBD

Glapp
Free

No monetization

GLP Together
Free

No monetization

GLP1Coach Target
$12.99/mo

or $99/year

Free vs. Paid Analysis

Free Models (Shotsy, Glapp, GLP Together)

  • Pros: Maximum TAM, rapid user acquisition, viral growth potential
  • Cons: Unsustainable (Glapp/GLP Together have no clear revenue path); require massive scale or premium tier conversion
  • Shotsy's Trap: Raised $2.25M but has revenue pressure—recently hiked price $29.99→$49.99 to offset burn
  • Insight: Free models work only if conversion strategy is clear (Shotsy failing here)

Freemium (Pep)

  • Pros: Balances acquisition + monetization; users can trial premium features
  • Cons: Free tier must be good enough to retain users; premium tier value prop unclear
  • Pep's Challenge: Moderate user base suggests freemium conversion is weak

Premium (MeAgain: $9.99/mo)

  • Pros: Clear value prop (meds sourcing justifies price); low churn (switching costs high)
  • Cons: Limits TAM to premium segment; high price ($9.99/mo + meds) caps conversion rate
  • MeAgain's Strength: Vertical integration ($199/mo meds) makes $9.99 app seem cheap

GLP1Coach Positioning: Premium at Accessible Price

$12.99/month or $99/year — Strategic Pricing Sweet Spot

  • Higher than Shotsy ($49.99/yr = $4.17/mo) because GLP1Coach is specialized, not generic tracking
  • Higher than MeAgain app-only ($9.99/mo) because GLP1Coach adds high-protein meal design + nausea coaching (justifies premium)
  • No integration with meds sourcing = lower price than MeAgain's full bundle
  • Value prop: "Premium nutrition coaching at yoga-app price" ($12.99 ≈ Planet Fitness/Peloton tier)
  • Conversion math: 1M users × 5% conversion × $155 ARPU = $7.75M Y1 revenue

GLP1Coach Competitive Positioning

Market Gap Analysis: Where GLP1Coach Wins

Gap 1: Nausea-Specific Meal Recommendations (CRITICAL)

Problem: 1 in 5 GLP-1 users experience moderate-to-severe nausea. Zero competitors offer nausea-triggered meal suggestions.

GLP1Coach Solution: AI learns user's nausea patterns (time of day, medication dose, food triggers) → recommends specific meals when nausea risk is high.

Competitive Advantage: Defensible, hard to copy (requires GLP-1-specific medical knowledge + user behavior ML)

Gap 2: High-Protein Meal Design for Muscle Preservation

Problem: Users must eat 80-120g protein daily but face appetite suppression. No competitor designs meals around this constraint.

GLP1Coach Solution: AI meal planner prioritizes dense, high-protein options (greek yogurt, eggs, cottage cheese) that are easier to consume. Meal design accounts for reduced appetite.

Competitive Advantage: Only GLP-1-specific nutrition coach offering this

Gap 3: Fridge-to-Meal Workflow (Reduces Food Waste)

Problem: Users struggle with food waste due to nausea → fear of food spoilage → grocery paralysis.

GLP1Coach Solution: "What's in my fridge?" workflow. User uploads fridge contents → AI suggests meals using what they have → reduces waste, saves money.

Competitive Advantage: Unique UX, solves real pain point competitors ignore

Gap 4: Psychiatric & Menstrual Side Effects Tracking

Problem: GLP-1s cause psychiatric side effects (anxiety, depression) and menstrual changes. Competitors only track physical side effects.

GLP1Coach Solution: Integrated mental health + GYN tracking (mood, sleep, cycle changes).

Competitive Advantage: Holistic health positioning

Recommended Positioning Statement

The nausea-friendly nutrition coach for GLP-1 users.

GLP1Coach is the only nutrition app designed for the GLP-1 journey. We help you:

  • Eat when nausea strikes (AI learns YOUR nausea patterns)
  • Build muscle during weight loss (80-120g protein meals tailored to reduced appetite)
  • Stop food waste (fridge-to-meal AI reduces spoilage)
  • Track side effects others ignore (psychiatric, menstrual, fatigue)

"Not just a tracker. A coach built for GLP-1 physiology."

Messaging Pillars

SWOT Analysis: GLP1Coach

Strengths
  • Only app offering nausea-specific meal coaching
  • High-protein design solves muscle preservation gap
  • Fridge-to-meal workflow reduces friction & food waste
  • Accessible price ($12.99) vs. MeAgain ($9.99 + meds)
  • AI photo meal logging + portion editing solves MeAgain's biggest UX pain
  • Holistic side effect tracking (psychiatric, menstrual)
  • 8-12M GLP-1 users = huge TAM
  • Market shift to specialization (AI apps winning over generic)
Weaknesses
  • No medication sourcing (can't match MeAgain's vertical integration)
  • New entrant (no brand recognition vs. MeAgain's 286K users)
  • Must compete with free/freemium options (Shotsy, Glapp)
  • Narrow focus (nutrition-only) vs. Pep/MeAgain's "all-in-one" appeal
  • Requires GLP-1-specific medical domain expertise (harder to build)
  • Nausea coaching requires user behavioral data (cold start problem)
  • AI meal design requires complex food database + nutrition ML
Opportunities
  • Nausea-specific positioning uncontested (white space)
  • MeAgain users frustrated by portion-size limitation
  • Shotsy users tired of app fragmentation (tracker + MyFitnessPal)
  • Psychiatric/menstrual side effect tracking resonates with women (60%+ of GLP-1 users)
  • GLP-1 market doubling to $255B by 2034 (massive TAM growth)
  • Telehealth integration (partner with GLP-1 clinics for referrals)
  • International expansion (multi-language support)
  • Vertical integration later (partner with nutrition brands, meal delivery services)
  • B2B partnerships (health plans, employer wellness programs)
Threats
  • MeAgain's entrenched position + high switching costs (meds + app)
  • Shotsy's VC funding ($2.25M) enables aggressive scaling
  • Apple/Google enter GLP-1 nutrition space (built-in Health app features)
  • New well-funded startups (e.g., GLP Together gets funding)
  • GLP-1 medication companies (Novo Nordisk, Eli Lilly) launch own apps
  • Free alternatives erode willingness to pay ($12.99 barrier)
  • Regulatory risk (food/nutrition claims require FDA scrutiny)
  • Medical liability (nausea coaching misinterpreted as medical advice)

Key Risks & Mitigation

Risk 1: Price Sensitivity

Free/freemium competitors (Shotsy, Glapp) may prevent $12.99/mo conversion.

Mitigation:

  • Position as "coaching" (premium), not "tracking" (commodity)
  • Emphasize nausea+protein features absent in free apps
  • Offer free trial (14-day) to prove value before paywall
  • Consider $6.99/mo tier to capture price-sensitive segment
Risk 2: Cold Start Problem (Nausea Coaching Requires Data)

AI nausea recommendations require 2+ weeks of user behavior data to train personalized models.

Mitigation:

  • Pre-train on anonymized user cohorts (nausea patterns by med/dose)
  • Bootstrap with clinician-vetted nausea meal library
  • Offer generic "nausea starter meals" day 1 (gradually personalize)
  • Partner with GLP-1 clinics for user cohort data
Risk 3: Medical Liability

Nausea coaching could be misinterpreted as medical advice; regulatory scrutiny on "health claims."

Mitigation:

  • Clear disclaimers: "Not a substitute for medical advice"
  • Partner with RD/MD advisors for clinical credibility
  • Focus on meal logistics, not symptom treatment
  • Insurance coverage for liability (professional liability policy)
  • Monitor FDA nutrition/health app guidance closely
Risk 4: MeAgain's Vertical Integration Moat

MeAgain's medication sourcing creates switching costs (users don't want to juggle meds + app).

Mitigation:

  • Don't compete on meds; compete on nutrition coaching (different value prop)
  • Partner with telehealth GLP-1 providers (e.g., Ro, Calibrate) for referrals
  • Target MeAgain users frustrated by portion-size limitation specifically
  • Position as "nutrition specialist" vs. MeAgain's "all-in-one" (allows co-existence)
Risk 5: Tech Giants Enter Market

Apple Health, Google Fit, or Samsung Health could add GLP-1 features, undercutting startups.

Mitigation:

  • Move fast to build brand loyalty before tech giants notice
  • Integrate deeply with Apple Health (don't compete, complement)
  • Build community (harder to replicate than features)
  • Pursue acquisition by tech giant (outcome: founder liquidity)

Go-to-Market Strategy

Phase 1: Build (Months 1-6)

Phase 2: Launch (Months 6-9)

Phase 3: Scale (Months 9-18)

Phase 4: Monetization Optimization (Months 18-24)

Recommended Next Steps

For Market Validation (Weeks 1-4)

  1. Interview 20-30 GLP-1 users (especially those with nausea) via Reddit/Discord to validate nausea-specific pain point
  2. Survey Shotsy/MeAgain users to understand app fragmentation friction
  3. Map regulatory landscape (FDA health claims, telehealth partnerships)
  4. Partner with 2-3 RDs to validate high-protein meal database approach

For MVP Development (Weeks 5-12)

  1. Build AI meal logging + portion editing (solves MeAgain's pain point)
  2. Create nausea-triggered meal recommendation engine (pre-trained on cohort data)
  3. Integrate side effect tracking (nausea, fatigue, psychiatric, menstrual)
  4. Design fridge-to-meal workflow (differentiator)

For Beta & Launch (Weeks 13-26)

  1. Recruit 500 beta testers from GLP-1 communities
  2. Iterate on nausea coaching based on user feedback
  3. Secure 3-5 RD/MD advisors for credibility
  4. Plan App Store launch + PR (TechCrunch, health media coverage)

Competitive Differentiation Summary

What Makes GLP1Coach Different Competitive Advantage
Nausea-specific meal coaching Zero competitors offer this; white space opportunity
High-protein meal design Addresses muscle preservation gap competitors ignore
Portion-editable AI logging Solves MeAgain's biggest UX pain point
Fridge-to-meal workflow Unique UX; reduces food waste + decision paralysis
Psychiatric/menstrual tracking Holistic health positioning; resonates with women (60%+ of GLP-1 users)
Accessible pricing ($12.99/mo) Premium value at consumer-friendly price (vs. MeAgain's $9.99 + meds)
GLP-1-focused (not generic nutrition) Depth in niche vs. breadth of generalist competitors
Research Sources:

GLP1Coach Competitive Analysis Report

Generated: April 16, 2026